Zkusit zdarma
Adaptive Biotechnologies Corporation

Adaptive Biotechnologies Corporation

ADPT
Cena:
$ 13.88
+0.01 (0.07%)
Valuace
85
Růst
45
Zdraví
75
Souhrn Finanční data Pro investory Předpovědi Zprávy Dividendy Zisky Návštěvnost webu Akcionáři
Souhrn
Finanční data
Pro investory
Předpovědi
Zprávy
Dividendy
Zisky
Návštěvnost webu
Akcionáři

Zprávy

Zahraniční články
Tiskové zprávy
Dokumenty ke stáhnutí
Adaptive Biotechnologies to Participate in Upcoming Investor Conferences

Adaptive Biotechnologies to Participate in Upcoming Investor Conferences

16:17 21-05-2026

SEATTLE, May 21, 2026 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a com...

Adaptive Biotechnologies to Participate in Upcoming Investor Conferences

Adaptive Biotechnologies to Participate in Upcoming Investor Conferences

16:17 21-05-2026

SEATTLE, May 21, 2026 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a com...

Adaptive Biotechnologies Corporation (ADPT) Q1 2026 Earnings Call Transcript

Adaptive Biotechnologies Corporation (ADPT) Q1 2026 Earnings Call Transcript

22:21 05-05-2026

Adaptive Biotechnologies Corporation (ADPT) Q1 2026 Earnings Call Transcript...

Adaptive Biotechnologies (ADPT) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates

Adaptive Biotechnologies (ADPT) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates

19:31 05-05-2026

While the top- and bottom-line numbers for Adaptive Biotechnologies (ADPT) give a sense of how the b...

Adaptive Biotechnologies (ADPT) Reports Q1 Loss, Beats Revenue Estimates

Adaptive Biotechnologies (ADPT) Reports Q1 Loss, Beats Revenue Estimates

19:05 05-05-2026

Adaptive Biotechnologies (ADPT) came out with a quarterly loss of $0.13 per share versus the Zacks C...

Adaptive Biotechnologies Reports First Quarter 2026 Financial Results

Adaptive Biotechnologies Reports First Quarter 2026 Financial Results

16:05 05-05-2026

SEATTLE, May 05, 2026 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (“Adaptive Biotechn...

Adaptive Biotechnologies' Chief Operating Officer Sold Over 19,000 Company Shares. Here's What That Means for Investors.

Adaptive Biotechnologies' Chief Operating Officer Sold Over 19,000 Company Shares. Here's What That Means for Investors.

17:29 04-05-2026

This immune diagnostics innovator reported a notable insider sale as it advances platforms for disea...

Adaptive Biotechnologies' COO Is Running a Systematic Sell Program — Here's What It Means

Adaptive Biotechnologies' COO Is Running a Systematic Sell Program — Here's What It Means

8:52 20-04-2026

This immune diagnostics firm reported a notable insider sale as it expands its clinical portfolio an...

Should You Sell Adaptive Biotechnologies (ADPT) After Its President and COO Sold 57,000 Shares?

Should You Sell Adaptive Biotechnologies (ADPT) After Its President and COO Sold 57,000 Shares?

10:37 18-04-2026

57,180 shares were sold for a total transaction value of approximately ~$826,000 across multiple day...

Adaptive Biotechnologies to Report First Quarter 2026 Financial Results on May 5, 2026

Adaptive Biotechnologies to Report First Quarter 2026 Financial Results on May 5, 2026

16:05 15-04-2026

SEATTLE, April 15, 2026 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a c...

Julie Rubinstein Sells 19,060 Shares of Adaptive Biotechnologies (NASDAQ:ADPT) Stock

Julie Rubinstein Sells 19,060 Shares of Adaptive Biotechnologies (NASDAQ:ADPT) Stock

4:58 15-04-2026

Adaptive Biotechnologies Corporation (NASDAQ: ADPT - Get Free Report) COO Julie Rubinstein sold 19,0...

Julie Rubinstein Sells 19,060 Shares of Adaptive Biotechnologies (NASDAQ:ADPT) Stock

Julie Rubinstein Sells 19,060 Shares of Adaptive Biotechnologies (NASDAQ:ADPT) Stock

4:58 15-04-2026

Adaptive Biotechnologies Corporation (NASDAQ: ADPT - Get Free Report) COO Julie Rubinstein sold 19,0...

Adaptive Biotech Insider Sells $554K as Revenue Jumps 55%, but Here's What Investors Should Focus On

Adaptive Biotech Insider Sells $554K as Revenue Jumps 55%, but Here's What Investors Should Focus On

9:13 08-04-2026

The President and COO of Adaptive Biotechnologies Corporation reported the sale of 38,120 shares for...

JPMorgan Chase & Co. Sells 799,246 Shares of Adaptive Biotechnologies Corporation $ADPT

JPMorgan Chase & Co. Sells 799,246 Shares of Adaptive Biotechnologies Corporation $ADPT

4:43 05-04-2026

JPMorgan Chase and Co. lowered its stake in shares of Adaptive Biotechnologies Corporation (NASDAQ: ...

Adaptive Biotech's President Trimmed Her Position. But what Remains is worth a look

Adaptive Biotech's President Trimmed Her Position. But what Remains is worth a look

20:08 30-03-2026

81,342 shares were sold for a total value of ~$1.21 million across multiple transactions from March ...

Adaptive Biotech Insider Sale of 180,000 Shares Tied to Tax Event as Stock Jumps 70% in a Year

Adaptive Biotech Insider Sale of 180,000 Shares Tied to Tax Event as Stock Jumps 70% in a Year

12:13 26-03-2026

An executive at Adaptive Biotechnologies reported the sale of 179,703 shares for about $2.37 million...

Adaptive Biotechnologies Insider Sells $1 Million in Stock After a Doubling in Share Price

Adaptive Biotechnologies Insider Sells $1 Million in Stock After a Doubling in Share Price

11:11 26-03-2026

Francis Lo, Chief People Officer at Adaptive Biotechnologies (ADPT +0.00%), reported the sale of a c...

Adaptive Biotechnologies (ADPT) Moves 5.8% Higher: Will This Strength Last?

Adaptive Biotechnologies (ADPT) Moves 5.8% Higher: Will This Strength Last?

8:16 16-03-2026

Adaptive Biotechnologies (ADPT) witnessed a jump in share price last session on above-average tradin...

Adaptive Biotechnologies Corporation $ADPT Position Lowered by Cinctive Capital Management LP

Adaptive Biotechnologies Corporation $ADPT Position Lowered by Cinctive Capital Management LP

5:36 16-03-2026

Cinctive Capital Management LP trimmed its position in Adaptive Biotechnologies Corporation (NASDAQ:...

Adaptive Biotechnologies (NASDAQ:ADPT) COO Sells $1,881,638.07 in Stock

Adaptive Biotechnologies (NASDAQ:ADPT) COO Sells $1,881,638.07 in Stock

4:21 16-03-2026

Adaptive Biotechnologies Corporation (NASDAQ: ADPT - Get Free Report) COO Julie Rubinstein sold 141,...

close

ADAPTIVE BIOTECHNOLOGIES REPORTS FOURTH QUARTER AND FULL YEAR 2025 FINANCIAL RESULTS

05-02-2026
SEATTLE, FEB. 05, 2026 (GLOBE NEWSWIRE) -- ADAPTIVE BIOTECHNOLOGIES CORPORATION (“ADAPTIVE BIOTECH...
Více zde

ADAPTIVE BIOTECHNOLOGIES TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCES

27-01-2026
SEATTLE, JAN. 27, 2026 (GLOBE NEWSWIRE) -- ADAPTIVE BIOTECHNOLOGIES CORPORATION (NASDAQ: ADPT), A CO...
Více zde

ADAPTIVE BIOTECHNOLOGIES TO REPORT FOURTH QUARTER AND FULL YEAR 2025 FINANCIAL RESULTS ON FEBRUARY 5, 2026

22-01-2026
SEATTLE, JAN. 22, 2026 (GLOBE NEWSWIRE) -- ADAPTIVE BIOTECHNOLOGIES CORPORATION (NASDAQ: ADPT), A CO...
Více zde

ADAPTIVE BIOTECHNOLOGIES ANNOUNCES PRELIMINARY FOURTH QUARTER AND FULL YEAR 2025 RESULTS

12-01-2026
SEATTLE, JAN. 12, 2026 (GLOBE NEWSWIRE) -- ADAPTIVE BIOTECHNOLOGIES CORPORATION (NASDAQ: ADPT), A CO...
Více zde

ADAPTIVE BIOTECHNOLOGIES TO PRESENT AT THE 44TH ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE

30-12-2025
SEATTLE, DEC. 30, 2025 (GLOBE NEWSWIRE) -- ADAPTIVE BIOTECHNOLOGIES CORPORATION (NASDAQ: ADPT), A CO...
Více zde

ADAPTIVE BIOTECHNOLOGIES ANNOUNCES TWO IMMUNE RECEPTOR LICENSING AGREEMENTS WITH PFIZER

15-12-2025
A TARGET DISCOVERY AGREEMENT TO IDENTIFY DISEASE-SPECIFIC T-CELL RECEPTORS (TCRS) IN RHEUMATOID ARTH...
Více zde

ADAPTIVE BIOTECHNOLOGIES TO PARTICIPATE IN JEFFERIES FIRESIDE CHAT SERIES ON MINIMAL RESIDUAL DISEASE

09-12-2025
SEATTLE, DEC. 09, 2025 (GLOBE NEWSWIRE) -- ADAPTIVE BIOTECHNOLOGIES CORPORATION (NASDAQ: ADPT), A CO...
Více zde

ADAPTIVE BIOTECHNOLOGIES SHOWCASES LEADERSHIP IN HEMATOLOGY-ONCOLOGY MRD WITH NEW CLONOSEQ® DATA DRIVING TREATMENT INTERVENTIONS AT 2025 ASH ANNUAL MEETING

06-12-2025
SEATTLE, DEC. 06, 2025 (GLOBE NEWSWIRE) -- ADAPTIVE BIOTECHNOLOGIES CORPORATION (NASDAQ: ADPT), A CO...
Více zde

ADAPTIVE BIOTECHNOLOGIES ANNOUNCES NEARLY 90 ABSTRACTS FEATURING CLONOSEQ® MRD TESTING ACROSS A RANGE OF BLOOD CANCERS TO BE PRESENTED AT THE 67TH ASH ANNUAL MEETING

24-11-2025
SEATTLE, NOV. 24, 2025 (GLOBE NEWSWIRE) -- ADAPTIVE BIOTECHNOLOGIES CORPORATION (NASDAQ: ADPT), A CO...
Více zde

ADAPTIVE BIOTECHNOLOGIES TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCES

06-11-2025
SEATTLE, NOV. 06, 2025 (GLOBE NEWSWIRE) -- ADAPTIVE BIOTECHNOLOGIES CORPORATION (NASDAQ: ADPT), A CO...
Více zde

ADAPTIVE BIOTECHNOLOGIES REPORTS THIRD QUARTER 2025 FINANCIAL RESULTS

05-11-2025
SEATTLE, NOV. 05, 2025 (GLOBE NEWSWIRE) -- ADAPTIVE BIOTECHNOLOGIES CORPORATION (“ADAPTIVE BIOTECH...
Více zde

ADAPTIVE BIOTECHNOLOGIES TO REPORT THIRD QUARTER 2025 FINANCIAL RESULTS ON NOVEMBER 5, 2025

15-10-2025
SEATTLE, OCT. 15, 2025 (GLOBE NEWSWIRE) -- ADAPTIVE BIOTECHNOLOGIES CORPORATION (NASDAQ: ADPT), A CO...
Více zde

ADAPTIVE BIOTECHNOLOGIES TO PARTICIPATE IN THE MORGAN STANLEY 23RD ANNUAL GLOBAL HEALTHCARE CONFERENCE

27-08-2025
SEATTLE, AUG. 27, 2025 (GLOBE NEWSWIRE) -- ADAPTIVE BIOTECHNOLOGIES CORPORATION (NASDAQ: ADPT), A CO...
Více zde

ADAPTIVE BIOTECHNOLOGIES REPORTS SECOND QUARTER 2025 FINANCIAL RESULTS

05-08-2025
SEATTLE, AUG. 05, 2025 (GLOBE NEWSWIRE) -- ADAPTIVE BIOTECHNOLOGIES CORPORATION (“ADAPTIVE BIOTECH...
Více zde

ADAPTIVE BIOTECHNOLOGIES TO REPORT SECOND QUARTER 2025 FINANCIAL RESULTS ON AUGUST 5, 2025

15-07-2025
SEATTLE, JULY 15, 2025 (GLOBE NEWSWIRE) -- ADAPTIVE BIOTECHNOLOGIES CORPORATION (NASDAQ: ADPT), A CO...
Více zde

ADAPTIVE BIOTECHNOLOGIES AND FLATIRON HEALTH ANNOUNCE INTEGRATION OF CLONOSEQ® MRD TESTING INTO ONCOEMR®

01-07-2025
CLONOSEQ® IS NOW INTEGRATED INTO FLATIRON HEALTH'S ONCOEMR®, SIMPLIFYING MRD TESTING ACCESS FOR OV...
Více zde

ADAPTIVE BIOTECHNOLOGIES HIGHLIGHTS NEW DATA AT 2025 ASCO ANNUAL MEETING AND EHA 2025 CONGRESS DEMONSTRATING HOW CLONOSEQ® MRD ASSESSMENT IS OPTIMIZING PATIENT CARE AND DRUG DEVELOPMENT IN LYMPHOID CANCERS

30-05-2025
SEATTLE, MAY 30, 2025 (GLOBE NEWSWIRE) -- ADAPTIVE BIOTECHNOLOGIES CORPORATION (NASDAQ: ADPT), A COM...
Více zde

ADAPTIVE BIOTECHNOLOGIES TO PARTICIPATE IN THE GOLDMAN SACHS 46TH ANNUAL GLOBAL HEALTHCARE CONFERENCE

28-05-2025
SEATTLE, MAY 28, 2025 (GLOBE NEWSWIRE) -- ADAPTIVE BIOTECHNOLOGIES CORPORATION (NASDAQ: ADPT), A COM...
Více zde

ADAPTIVE BIOTECHNOLOGIES REPORTS FIRST QUARTER 2025 FINANCIAL RESULTS

01-05-2025
SEATTLE, MAY 01, 2025 (GLOBE NEWSWIRE) -- ADAPTIVE BIOTECHNOLOGIES CORPORATION (“ADAPTIVE BIOTECHN...
Více zde

ADAPTIVE BIOTECHNOLOGIES TO REPORT FIRST QUARTER 2025 FINANCIAL RESULTS ON MAY 1, 2025

10-04-2025
SEATTLE, APRIL 10, 2025 (GLOBE NEWSWIRE) -- ADAPTIVE BIOTECHNOLOGIES CORPORATION (NASDAQ: ADPT), A C...
Více zde

ADAPTIVE BIOTECHNOLOGIES RECEIVES EXPANDED MEDICARE COVERAGE OF CLONOSEQ® FOR SURVEILLANCE IN MANTLE CELL LYMPHOMA

08-04-2025
CLONOSEQ IS NOW COVERED TO MONITOR FOR RECURRENCE IN MCL PATIENTS WHO ARE IN TREATMENT-FREE REMISSIO...
Více zde

ADAPTIVE BIOTECHNOLOGIES LAUNCHES ASSAY ENHANCEMENTS TO INCREASE CLONOSEQ® SENSITIVITY FOR CLINICAL MRD DETECTION IN DIFFUSE LARGE B-CELL LYMPHOMA

11-03-2025
ENHANCED ASSAY GRANTED APPROVAL BY NEW YORK STATE'S CLINICAL LAB EVALUATION PROGRAM (CLEP) FOR PATIE...
Více zde

ADAPTIVE BIOTECHNOLOGIES REPORTS FOURTH QUARTER AND FULL YEAR 2024 FINANCIAL RESULTS

11-02-2025
SEATTLE, FEB. 11, 2025 (GLOBE NEWSWIRE) -- ADAPTIVE BIOTECHNOLOGIES CORPORATION (“ADAPTIVE BIOTECH...
Více zde

ADAPTIVE BIOTECHNOLOGIES TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCES

05-02-2025
SEATTLE, FEB. 05, 2025 (GLOBE NEWSWIRE) -- ADAPTIVE BIOTECHNOLOGIES CORPORATION (“ADAPTIVE BIOTECH...
Více zde

ADAPTIVE BIOTECHNOLOGIES TO REPORT FOURTH QUARTER AND FULL YEAR 2024 FINANCIAL RESULTS ON FEBRUARY 11, 2025

22-01-2025
SEATTLE, JAN. 22, 2025 (GLOBE NEWSWIRE) -- ADAPTIVE BIOTECHNOLOGIES CORPORATION (NASDAQ: ADPT), A CO...
Více zde

ADAPTIVE BIOTECHNOLOGIES AND NEOGENOMICS PARTNER TO EXPAND ACCESS TO PERSONALIZED DISEASE MONITORING FOR BLOOD CANCER PATIENTS

14-01-2025
PAIRING ADAPTIVE BIOTECHNOLOGIES' CLONOSEQ MRD RESULTS WITH NEOGENOMICS' COMPASS AND CHART ASSESSMEN...
Více zde

ADAPTIVE BIOTECHNOLOGIES ANNOUNCES CLINICAL LAB FEE SCHEDULE RATE OF $2,007 FOR CLONOSEQ® TEST FOR MINIMAL RESIDUAL DISEASE ASSESSMENT IS EFFECTIVE AS OF JANUARY 1ST, 2025

07-01-2025
SEATTLE, JAN. 07, 2025 (GLOBE NEWSWIRE) -- ADAPTIVE BIOTECHNOLOGIES CORPORATION (NASDAQ: ADPT), A CO...
Více zde

ADAPTIVE BIOTECHNOLOGIES TO PRESENT AT THE 43RD ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE

02-01-2025
SEATTLE, JAN. 02, 2025 (GLOBE NEWSWIRE) -- ADAPTIVE BIOTECHNOLOGIES CORPORATION (NASDAQ: ADPT), A CO...
Více zde

ADAPTIVE BIOTECHNOLOGIES ANNOUNCES NEW DATA AT THE 66TH ASH ANNUAL MEETING HIGHLIGHTING ADVANCES IN MRD TESTING WITH CLONOSEQ® AND ITS IMPACT ON BLOOD CANCER TREATMENT DECISIONS

07-12-2024
NEW DATA DEMONSTRATE THE ACTIONABILITY OF CLONOSEQ FOR TAILORING TREATMENT DECISIONS IN PATIENTS WIT...
Více zde

ADAPTIVE BIOTECHNOLOGIES ANNOUNCES OVER 65 ABSTRACTS FEATURING CLONOSEQ® MRD TESTING ACROSS A RANGE OF BLOOD CANCERS TO BE PRESENTED AT THE 66TH ASH ANNUAL MEETING

03-12-2024
SEATTLE, DEC. 03, 2024 (GLOBE NEWSWIRE) -- ADAPTIVE BIOTECHNOLOGIES CORPORATION (NASDAQ: ADPT), A CO...
Více zde

close

Datum Typ Otevřít EDGAR Stáhnout dokument
2026-02-05 00:00:008-KStáhnout
2026-01-12 00:00:008-KStáhnout
2025-12-30 00:00:008-KStáhnout
2025-11-05 00:00:008-KStáhnout
2025-11-05 00:00:0010-QStáhnout
2025-08-18 01:00:008-KStáhnout
2025-08-18 00:00:008-KStáhnout
2025-08-05 01:00:008-KStáhnout
2025-08-05 01:00:0010-QStáhnout
2025-08-05 00:00:008-KStáhnout
2025-08-05 00:00:0010-QStáhnout
2025-06-12 01:00:008-KStáhnout
2025-06-12 00:00:008-KStáhnout
2025-05-01 01:00:008-KStáhnout
2025-05-01 01:00:0010-QStáhnout
2025-05-01 00:00:008-KStáhnout
2025-05-01 00:00:0010-QStáhnout
2025-03-03 00:00:0010-KStáhnout
2025-03-02 23:00:0010-KStáhnout
2025-02-11 00:00:008-KStáhnout
2025-02-10 23:00:008-KStáhnout
2024-11-07 00:00:008-KStáhnout
2024-11-07 00:00:0010-QStáhnout
2024-11-06 23:00:008-KStáhnout
2024-11-06 23:00:0010-QStáhnout
2024-08-01 01:00:008-KStáhnout
2024-08-01 01:00:0010-QStáhnout
2024-08-01 00:00:008-KStáhnout
2024-08-01 00:00:0010-QStáhnout
2024-06-11 01:00:008-KStáhnout
2024-06-11 00:00:008-KStáhnout
2024-05-07 01:00:008-KStáhnout
2024-05-07 01:00:0010-QStáhnout
2024-05-07 00:00:008-KStáhnout
2024-05-07 00:00:0010-QStáhnout
2024-04-09 01:00:008-KStáhnout
2024-04-09 00:00:008-KStáhnout
2024-04-05 01:00:008-KStáhnout
2024-04-05 00:00:008-KStáhnout
2024-04-02 01:00:008-KStáhnout
2024-04-02 00:00:008-KStáhnout
2024-02-29 00:00:0010-KStáhnout
2024-02-28 23:00:0010-KStáhnout
2024-02-14 00:00:008-KStáhnout
2024-02-13 23:00:008-KStáhnout
2023-11-09 00:00:008-KStáhnout
2023-11-09 00:00:0010-QStáhnout
2023-11-08 23:00:008-KStáhnout
2023-11-08 23:00:0010-QStáhnout
2023-09-01 01:00:008-KStáhnout
2023-09-01 00:00:008-KStáhnout
2023-08-02 01:00:008-KStáhnout
2023-08-02 01:00:0010-QStáhnout
2023-08-02 00:00:008-KStáhnout
2023-08-02 00:00:0010-QStáhnout
2023-07-03 01:00:008-KStáhnout
2023-07-03 00:00:008-KStáhnout
2023-06-13 01:00:008-KStáhnout
2023-06-13 00:00:008-KStáhnout
2023-05-09 01:00:008-KStáhnout
2023-05-09 00:00:008-KStáhnout
2023-05-03 01:00:008-KStáhnout
2023-05-03 01:00:0010-QStáhnout
2023-05-03 00:00:008-KStáhnout
2023-05-03 00:00:0010-QStáhnout
2023-04-11 01:00:008-KStáhnout
2023-04-11 00:00:008-KStáhnout
2023-02-14 00:00:008-KStáhnout
2023-02-14 00:00:0010-KStáhnout
2023-02-13 23:00:008-KStáhnout
2023-02-13 23:00:0010-KStáhnout
2022-11-03 00:00:008-KStáhnout
2022-11-03 00:00:0010-QStáhnout
2022-11-02 23:00:008-KStáhnout
2022-11-02 23:00:0010-QStáhnout
2022-08-03 01:00:008-KStáhnout
2022-08-03 01:00:0010-QStáhnout
2022-08-03 00:00:008-KStáhnout
2022-08-03 00:00:0010-QStáhnout
2022-06-14 01:00:008-KStáhnout
2022-06-14 00:00:008-KStáhnout
2022-05-04 01:00:008-KStáhnout
2022-05-04 01:00:0010-QStáhnout
2022-05-04 00:00:008-KStáhnout
2022-05-04 00:00:0010-QStáhnout
2022-03-25 00:00:008-KStáhnout
2022-03-24 23:00:008-KStáhnout
2022-03-11 00:00:008-KStáhnout
2022-03-10 23:00:008-KStáhnout
2022-02-15 00:00:008-KStáhnout
2022-02-15 00:00:0010-KStáhnout
2022-02-14 23:00:008-KStáhnout
2022-02-14 23:00:0010-KStáhnout
2022-01-10 00:00:008-KStáhnout
2022-01-09 23:00:008-KStáhnout
2021-11-03 00:00:008-KStáhnout
2021-11-03 00:00:0010-QStáhnout
2021-11-02 23:00:008-KStáhnout
2021-11-02 23:00:0010-QStáhnout
2021-08-04 01:00:008-KStáhnout
2021-08-04 01:00:0010-QStáhnout
2021-08-04 00:00:008-KStáhnout
2021-08-04 00:00:0010-QStáhnout
2021-06-14 01:00:008-KStáhnout
2021-06-14 00:00:008-KStáhnout
2021-05-05 01:00:008-KStáhnout
2021-05-05 01:00:0010-QStáhnout
2021-05-05 00:00:008-KStáhnout
2021-05-05 00:00:0010-QStáhnout
2021-03-17 00:00:008-KStáhnout
2021-03-16 23:00:008-KStáhnout
2021-03-05 00:00:008-KStáhnout
2021-03-04 23:00:008-KStáhnout
2021-03-02 00:00:008-KStáhnout
2021-03-01 23:00:008-KStáhnout
2021-02-24 00:00:008-KStáhnout
2021-02-24 00:00:0010-KStáhnout
2021-02-23 23:00:008-KStáhnout
2021-02-23 23:00:0010-KStáhnout
2021-01-27 00:00:008-KStáhnout
2021-01-26 23:00:008-KStáhnout
2020-11-12 00:00:008-KStáhnout
2020-11-11 23:00:008-KStáhnout
2020-11-10 00:00:008-KStáhnout
2020-11-10 00:00:0010-QStáhnout
2020-11-09 23:00:008-KStáhnout
2020-11-09 23:00:0010-QStáhnout
2020-10-16 01:00:008-KStáhnout
2020-10-16 00:00:008-KStáhnout
2020-08-21 01:00:008-KStáhnout
2020-08-21 00:00:008-KStáhnout
2020-08-10 01:00:008-KStáhnout
2020-08-10 01:00:0010-QStáhnout
2020-08-10 00:00:008-KStáhnout
2020-08-10 00:00:0010-QStáhnout
2020-07-16 01:00:008-KStáhnout
2020-07-16 00:00:008-KStáhnout
2020-06-26 01:00:008-KStáhnout
2020-06-26 00:00:008-KStáhnout
2020-06-16 01:00:008-KStáhnout
2020-06-16 00:00:008-KStáhnout
2020-05-12 01:00:008-KStáhnout
2020-05-12 01:00:0010-QStáhnout
2020-05-12 00:00:008-KStáhnout
2020-05-12 00:00:0010-QStáhnout
2020-05-05 01:00:008-KStáhnout
2020-05-05 00:00:008-KStáhnout
2020-03-20 00:00:008-KStáhnout
2020-03-19 23:00:008-KStáhnout
2020-02-26 00:00:008-KStáhnout
2020-02-26 00:00:0010-KStáhnout
2020-02-25 23:00:008-KStáhnout
2020-02-25 23:00:0010-KStáhnout
2020-02-18 00:00:008-KStáhnout
2020-02-17 23:00:008-KStáhnout
2020-01-24 00:00:008-KStáhnout
2020-01-23 23:00:008-KStáhnout
2020-01-08 00:00:008-KStáhnout
2020-01-07 23:00:008-KStáhnout
2019-11-12 00:00:008-KStáhnout
2019-11-12 00:00:0010-QStáhnout
2019-11-11 23:00:008-KStáhnout
2019-11-11 23:00:0010-QStáhnout
2019-09-24 01:00:008-KStáhnout
2019-09-24 00:00:008-KStáhnout
2019-08-13 01:00:008-KStáhnout
2019-08-13 01:00:0010-QStáhnout
2019-08-13 00:00:008-KStáhnout
2019-08-13 00:00:0010-QStáhnout
2019-08-07 01:00:008-KStáhnout
2019-08-07 00:00:008-KStáhnout
2019-08-02 01:00:008-KStáhnout
2019-08-02 00:00:008-KStáhnout
2019-07-01 01:00:008-KStáhnout
2019-07-01 00:00:008-KStáhnout
preloader